The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,042,433 in first-year total cost, median $521,217.
Most frequent study sections
- Special Emphasis Panel[ZDA1 IXN-O (10)]2
Most frequent institutions
- UNIVERSITY OF PENNSYLVANIA1
- VIRGINIA COMMONWEALTH UNIVERSITY1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2020 | A Clinical Laboratory with Integrated Neuroscience (CLIN) for Early Evaluation of Medications for Substance Use Disorders1UG1DA050209-01 | CHILDRESS, ANNA ROSEKAMPMAN, KYLE MATTHEW | UNIVERSITY OF PENNSYLVANIA, PA | $529,915 | ZDA1 |
| 2020 | Laboratories for Early Clinical Evaluation of Pharmacotherapies for Substance Use Disorders1UG1DA050207-01 | ARIAS, ALBERT JOSEPHMOELLER, FREDERICK GERARD | VIRGINIA COMMONWEALTH UNIVERSITY, VA | $512,518 | ZDA1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.